 |
Challenging Cases in Acute Blood Pressure Management: Putting the Guidelines Into Practice CME/CE Mark J. Alberts, MD; Anish Bhardwaj, MD, FAHA, FCCM; Lori M. Massaro, RN, MSN, CRNP; Arthur M. Pancioli, MD Author Information and Disclosures Release Date: June 25, 2008; Valid for credit through June 25, 2009 | Physicians - maximum of 2.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 2.0 ANCC contact hours (0.0 contact hours in the area of pharmacology) | | This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Challenging Cases in Acute Blood Pressure Management: Putting the Guidelines Into Practice" symposium held at the Hilton New Orleans Riverside in New Orleans, La., on February 21, 2008.
To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details. Contents of This CME/CE Activity Legal DisclaimerThe material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 OptumHealth Education |
|
|
Learning Objectives Upon completion of this activity, participants should be able to: - Evaluate the role of the emergency department in optimizing care of patients with stroke
- Formulate treatment strategies for acute blood pressure management of acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage,
as recommended in currently available AHA/ASA guidelines
- Explain the roles of the stroke team members in managing neurologic emergencies
Author Disclosures Chair
Mark J. Alberts, MD
Disclosure: Advisory Boards: AGA Medical; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim;
Bristol-Myers Squibb; Eli Lilly and Co.; Genentech; Kos; The Medicines Company; Merck & Co., Inc.; Novo Nordisk A/S; Pfizer Inc; and sanofi-aventis. Consultant: AGA Medical; AstraZeneca Pharmaceuticals LP; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eli Lilly and Co.; Genentech; Kos; The Medicines Company; Merck & Co., Inc.; Novo Nordisk A/S; PDL BioPharma, Inc.; Pfizer Inc; and sanofi-aventis. Grants/Research Support: AGA
Medical, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim, Bristol-Myers Squibb, Novo Nordisk A/S, PhotoThera, sanofi-aventis, and Schering-Plough. Speakers Bureaus: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim; Bristol-Myers Squibb; diaDexus; Genentech; The Medicines Company; Novo Nordisk A/S; PDL BioPharma, Inc.; and sanofi-aventis. Other Financial or Material Support: AGA Medical; AstraZeneca Pharmaceuticals LP; Bayer; Boehringer
Ingelheim; Bristol-Myers Squibb; diaDexus; Eli Lilly and Co.; Genentech; Kos; The Medicines Company; Merck & Co., Inc.; Novo Nordisk A/S; PDL BioPharma, Inc.; Pfizer Inc; sanofi-aventis; Schering-Plough; and TAP Pharmaceutical Products Inc. Dr. Alberts does intend to discuss unapproved/investigative use of commercial products/devices. Faculty
Anish Bhardwaj, MD, FAHA, FCCM
Disclosure: Advisory Board: PDL BioPharma, Inc. Speakers Bureaus: Astellas Pharma Inc. Dr. Bhardwaj does not intend to discuss unapproved/investigative use of commercial products/devices. Lori M. Massaro, RN, MSN, CRNP
Disclosure: Consultant: PDL BioPharma, Inc. Speakers Bureaus: PDL BioPharma,
Inc. Ms. Massaro does not intend to discuss unapproved/investigative use of commercial products/devices. Arthur M. Pancioli, MD
Disclosure: Grant Research Support: PDL BioPharma, Inc. Dr. Pancioli does not intend to discuss unapproved/investigative use of commercial products/devices. |
 |
OptumHealth Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
OptumHealth Education designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
OptumHealth Education is an approved provider of continuing nursing education by the Utah Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. The participant will be awarded 2 contact hours of credit for attendance and completion of supplemental materials. This activity is sponsored by OptumHealth Education (formerly i3 CME).
Contact This Provider
|
|
